Opendata, web and dolomites

spinitCompanion

A point of care device to provide real-time blood analysis for chronic diseases.

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 spinitCompanion project word cloud

Explore the words cloud of the spinitCompanion project. It provides you a very rough idea of what is the project "spinitCompanion" about.

healthcare    instrument    quantifies    times    sme    strategy    independent    removing    patents    markets    cover    diagnosis    accuracy    biosurfit    laboratories    patient    health    keeping    economic    sustainability    significantly    flagship    waiting    reader    panel    performing    centralised    efficiency    tool    tests    clinical    spinitcompanion    setting    correct    multiple    fits    protected    spinit    poc    care    standard    healthy    reg    near    cartridges    positive    minutes    people    marketing    regulation    compliance    provides    recurrently    disposable    productivity    social    vitro    blood    faster    device    doctors    analyser    solution    accurate    outlined    reliance    time    cheaper    responds    market    leverages    full    patients    vision    longer    active    smartphone    assays    innovative    ivd    ip    point    scenario    drop    manufacturing    commercialization    single    treatment    diagnostic    chronic    urgent    competitiveness    plan    central    diseases    public    platform    lab   

Project "spinitCompanion" data sheet

The following table provides information about the project.

Coordinator
BIOSURFIT SA 

Organization address
address: CENTRO EMPRESARIAL DE AVEIRO
city: AVEIRO
postcode: 3810 744
website: www.biosurfit.com

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Portugal [PT]
 Project website http://biosurfit.com/spinit-available-tests/
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3.1.3. (Treating and managing disease)
 Code Call H2020-SMEINST-1-2016-2017
 Funding Scheme SME-1
 Starting year 2016
 Duration (year-month-day) from 2016-12-01   to  2017-04-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    BIOSURFIT SA PT (AVEIRO) coordinator 50˙000.00

Map

 Project objective

biosurfit have developed an In Vitro Diagnostic (IVD) tool - the spinitCompanion - enabling the testing for a wide range of blood parameters that are needed for urgent and accurate diagnosis in order to deliver the correct treatment for chronic diseases. The solution comprises an analyser, a smartphone application and disposable cartridges to process a single drop of blood and provide doctors with real time results. biosurfit's user-friendly device allows for multiple panel blood assays - near or at the patient Point of Care (PoC) - with the use of one single platform. This solution is cheaper and significantly faster than performing such tests recurrently, as chronic conditions require, in a standard lab setting, Furthermore the technology provides a high level of accuracy (comparable to established central lab tests), and quantifies the presence of specific clinical parameters in less than 10 minutes. biosurfit’s solution responds to two main objectives outlined in the EU Health Strategy, which cover both relevant economic and social aspects: 1) Improve the sustainability and efficiency of social and healthcare system 2) Keeping people healthy and active for longer has a positive impact on productivity and competitiveness. The spinitCompanion fully fits with biosurfit’s overall strategy with an innovative product that leverages on the same flagship technology platform - spinit® reader - already on the market and now protected with 20 independent patents. biosurfit’s vision and main goal is to deliver blood analysis testing to the public, removing its reliance on centralised laboratories and long waiting times both for patients and doctors. In this scenario, the SME Instrument project will enable an important step in achieving EU regulation compliance and the development of a full manufacturing and commercialization plan, and strong IP/marketing strategy based on in-depth analysis of European markets.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "SPINITCOMPANION" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "SPINITCOMPANION" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.3.)

DIAdIC (2019)

Evaluation of Dyadic Psychoeducational Interventions for People with Advanced Cancer and their Informal Caregivers (DIAdIC): An international randomized controlled trial

Read More  

ENDOSCAPE (2019)

ENDOSCAPE, a clinically applicable non-viral gene delivery technology

Read More  

LEGACy (2019)

CeLac and European consortium for a personalized medicine approach to Gastric Cancer

Read More